Literature DB >> 30458323

Hybrid Surgery for Nontaper or Nonstump Lesions in Symptomatic Subacute or Chronic Internal Carotid Occlusion: A Better Solution.

Jun Li1, Chao Wang1, Sili Zou1, Yandong Liu1, Lefeng Qu2.   

Abstract

BACKGROUND: Internal carotid artery occlusion (ICAO) causes transient ischemic attack and cerebral infarction. ICAO management remains clinically challenging. We discuss a hybrid treatment combining carotid endarterectomy and endovascular intervention (E-I) for patients with nontaper or nonstump lesions of symptomatic ICAO.
METHODS: We treated 32 patients with consecutive nontaper or nonstump ICAO with neurological symptoms with hybrid treatment or E-I. We analyzed the epidemiology, symptoms, angiographic morphology, technical success rate, and perioperative complications.
RESULTS: Of the 32 patients, 17 were treated with hybrid surgery and 15, E-I. The demographic data and lesion characteristics were similar between the 2 groups. The overall recanalization success rate was 71.9%. The rate for hybrid surgery was better than that for E-I (88.2% vs. 53.3%). The postoperative cerebral hyperperfusion rate showed no difference between the 2 groups (11.8% vs. 6.7%). Ipsilateral cerebral perfusion improved after treatment. The mean transition time and time to peak were greater than normal (normal values, <6 seconds and <8 seconds, respectively). Both increased significantly after treatment (mean transition time, 11.30 seconds vs. 7.25 seconds; time to peak, 19.30 seconds vs. 15.50 seconds). The incidence of perioperative complications from hybrid surgery was less than that with E-I (5.9% vs. 40.0%). Recurrent cerebrovascular events (5.9% vs. 13.3%) and the 3-month modified Rankin scale score (2.76 ± 0.66 vs. 2.93 ± 0.70) did not differ between the 2 groups.
CONCLUSIONS: Recanalization of nontaper or nonstump ICAO with hybrid treatment was more successful than that with E-I, with fewer perioperative complications. The carotid endarterectomy procedure enables easier wire crossing across the occlusion and reduces potential technology-related complications by requiring a shorter lesion and fewer dissections and minimizing the effect of calcification.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Endovascular; Hybrid surgery; Nonstump; Nontaper; Symptomatic chronic internal carotid occlusion

Mesh:

Year:  2018        PMID: 30458323     DOI: 10.1016/j.wneu.2018.11.075

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  6 in total

Review 1.  Management of De Novo Carotid Stenosis and Postintervention Restenosis-Carotid Endarterectomy Versus Carotid Artery Stenting-a Review of Literature.

Authors:  Runqi Wangqin; Paul R Krafft; Keaton Piper; Jay Kumar; Kaya Xu; Maxim Mokin; Zeguang Ren
Journal:  Transl Stroke Res       Date:  2019-02-22       Impact factor: 6.829

Review 2.  Surgical therapy for chronic internal carotid artery occlusion: a systematic review and meta-analysis.

Authors:  Genmao Cao; Jie Hu; Qinqin Tian; Honglin Dong; Wayne W Zhang
Journal:  Updates Surg       Date:  2021-04-17

Review 3.  Recanalization of the Chronically Occluded Internal Carotid Artery: Review of the Literature.

Authors:  Mario Zanaty; Jorge A Roa; Pascal M Jabbour; Edgar A Samaniego; David M Hasan
Journal:  World Neurosurg X       Date:  2019-11-21

4.  Combined Endovascular and Surgical Treatment of Chronic Carotid Artery Occlusion: Hybrid Operation.

Authors:  Long Yan; Zhe Wang; Zhanchuan Liu; Haoyuan Yin; Xuan Chen
Journal:  Biomed Res Int       Date:  2020-11-28       Impact factor: 3.411

5.  Hybrid surgery versus endovascular intervention for patients with chronic internal carotid artery occlusion: A single-center retrospective study.

Authors:  Tao Sun; Yiming He; Fei Wang; Bo Mao; Mengtao Han; Peng Zhao; Wei Wu; Yunyan Wang; Xingang Li; Donghai Wang
Journal:  Front Surg       Date:  2022-09-02

6.  A Treatment Option for Symptomatic Chronic Complete Internal Carotid Artery Occlusion: Hybrid Surgery.

Authors:  Yunna Yang; Xingju Liu; Rong Wang; Yan Zhang; Dong Zhang; Jizong Zhao
Journal:  Front Neurosci       Date:  2020-04-28       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.